Found: 35
Select item for more details and to access through your institution.
Discordance in PD-L1 expression using 22C3 and SP142 assays between primary and metastatic triple-negative breast cancer.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 6, p. 855, doi. 10.1007/s00428-023-03634-2
- By:
- Publication type:
- Article
A case of vasculogenic mesenchymal tumor in the mediastinum: whole-exome sequencing reveals origin from pre-existing germ cell tumor.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 482, n. 5, p. 923, doi. 10.1007/s00428-023-03529-2
- By:
- Publication type:
- Article
Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2021, v. 478, n. 6, p. 1161, doi. 10.1007/s00428-021-03017-5
- By:
- Publication type:
- Article
Mismatch Repair Protein Expression in Endometrial Cancer: Assessing Concordance and Unveiling Pitfalls in Two Different Immunohistochemistry Assays.
- Published in:
- Journal of Personalized Medicine, 2023, v. 13, n. 8, p. 1260, doi. 10.3390/jpm13081260
- By:
- Publication type:
- Article
A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2017, v. 47, n. 1, p. 39, doi. 10.1093/jjco/hyw143
- By:
- Publication type:
- Article
Feasibility Study of Combination Chemotherapy with Paclitaxel, Doxorubicin and Cisplatin without Prophylactic Granulocyte Colony-stimulating Factor Injection for Intermediate-to-high Risk or Recurrent Endometrial Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2014, v. 44, n. 11, p. 1040, doi. 10.1093/jjco/hyu124
- By:
- Publication type:
- Article
Changes in HER3 expression profiles between primary and recurrent gynecological cancers.
- Published in:
- Cancer Cell International, 2023, p. 1, doi. 10.1186/s12935-022-02844-z
- By:
- Publication type:
- Article
Integrative prognostic analysis of tumor–infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 197, n. 2, p. 287, doi. 10.1007/s10549-022-06787-x
- By:
- Publication type:
- Article
Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience.
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 12, p. 2275, doi. 10.1007/s10147-021-02021-8
- By:
- Publication type:
- Article
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
- By:
- Publication type:
- Article
Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 1, p. 168, doi. 10.1007/s10147-015-0859-7
- By:
- Publication type:
- Article
The Risk of Ovarian Malignancy Algorithm (ROMA) as a Predictive Marker of Peritoneal Dissemination in Epithelial Ovarian Cancer Patients.
- Published in:
- Oncology Research & Treatment, 2015, v. 38, n. 6, p. 276, doi. 10.1159/000430858
- By:
- Publication type:
- Article
Subclinical thiamine deficiency identified by preoperative evaluation in an ovarian cancer patient: Diagnosis and the need for preoperative thiamine measurement.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with metastatic or recurrent breast cancer treated using capecitabine: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study.
- Published in:
- Journal of Gynecologic Oncology, 2017, v. 28, n. 1, p. 1, doi. 10.3802/jgo.2017.28.e25
- By:
- Publication type:
- Article
Advanced Mucinous Adenocarcinoma Arising from a Mature Cystic Teratoma: A Case Report and Literature Review.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Impact of adjuvant chemotherapy and radiotherapy on tumour-infiltrating lymphocytes and PD-L1 expression in metastatic breast cancer.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 4, p. 568, doi. 10.1038/s41416-022-02072-2
- By:
- Publication type:
- Article
Development of a Detection System for ESR1 Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 12, p. 2040, doi. 10.3390/diagnostics13122040
- By:
- Publication type:
- Article
Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
- Published in:
- International Journal of Surgical Pathology, 2023, v. 31, n. 5, p. 778, doi. 10.1177/10668969221133348
- By:
- Publication type:
- Article
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Association between effector-type regulatory T cells and immune checkpoint expression on CD8<sup>+</sup> T cells in malignant ascites from epithelial ovarian cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma.
- Published in:
- Oncology, 2022, v. 100, n. 7, p. 370, doi. 10.1159/000524500
- By:
- Publication type:
- Article
Treatment Outcome of Second-Line Chemotherapy for Gynecologic Carcinosarcoma.
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 699, doi. 10.1159/000507333
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy promotes the expression of HER3 in patients with ovarian cancer.
- Published in:
- Oncology Letters, 2020, v. 20, n. 6, p. N.PAG, doi. 10.3892/ol.2020.12200
- By:
- Publication type:
- Article
HER3 protein expression as a risk factor for post-operative recurrence in patients with early-stage adenocarcinoma and adenosquamous carcinoma of the cervix.
- Published in:
- Oncology Letters, 2020, v. 20, n. 4, p. N.PAG
- By:
- Publication type:
- Article
Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1157789
- By:
- Publication type:
- Article
Efficacy and safety of nivolumab monotherapy in patients with unresectable clear cell sarcoma and alveolar soft part sarcoma (OSCAR Trial/NCCH1510).
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 22, p. 3836, doi. 10.1002/cncr.35483
- By:
- Publication type:
- Article
PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system.
- Published in:
- Cancer Science, 2018, v. 109, n. 8, p. 2558, doi. 10.1111/cas.13696
- By:
- Publication type:
- Article
Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumors.
- Published in:
- Cancer Science, 2017, v. 108, n. 9, p. 1834, doi. 10.1111/cas.13307
- By:
- Publication type:
- Article
Drug induced interstitial lung disease in oncology phase I trials.
- Published in:
- Cancer Science, 2016, v. 107, n. 12, p. 1830, doi. 10.1111/cas.13087
- By:
- Publication type:
- Article
Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37616-w
- By:
- Publication type:
- Article
Mesothelin expression in gynecologic carcinosarcoma: clinicopathological significance and correlation with HER2 expression.
- Published in:
- Journal of Gynecologic Oncology, 2024, v. 35, n. 2, p. 1, doi. 10.3802/jgo.2024.35.e11
- By:
- Publication type:
- Article
High expression of folate receptor alpha is associated with poor prognosis in patients with cervical cancer.
- Published in:
- Journal of Gynecologic Oncology, 2022, v. 33, n. 6, p. 1, doi. 10.3802/jgo.2022.33.e82
- By:
- Publication type:
- Article
Clinicopathological and prognostic features of HER2-null and HER2-low advanced breast cancer treated with eribulin or capecitabine.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 6, p. 1037, doi. 10.1007/s12282-024-01617-y
- By:
- Publication type:
- Article